TREA

79372184 - TAZOVID

Follow

Information

  • Trademark
  • 79372184
  • Serial Number
    79372184
  • Filing Date
    April 13, 2023
    a year ago
  • Transaction Date
    July 03, 2024
    3 days ago
  • Status Date
    June 17, 2024
    19 days ago
  • Published for Opposition Date
    July 23, 2024
    16 days from now
  • Location Date
    June 17, 2024
    19 days ago
  • Status Code
    681
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    EISNACH, MICHAEL PATRI
  • Attorney Docket Number
    BYL0191TUS
    Attorney Name
    Michelle P. Ciotola
    Law Office Assigned Location Code
    L40
  • Owners
Information
Mark Drawing Code
4
Mark Identification
TAZOVID
Case File Statements
  • GS0051: Medicines for human purposes for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Pharmaceutical preparations for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Capsules being medicines for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Drugs for medical purposes for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; vaccines; Ointments for pharmaceutical purposes for the treatment of skin conditions; Medicines in the form of tablets for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; biocides; Dietetic preparations adapted for medical purposes; Depuratives for the body; Medicines for veterinary purposes for the treatment of COVID-19; dental lacquer
Case File Event Statements
  • 6/23/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/27/2023 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/10/2024 - 5 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/22/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 1/17/2024 - 5 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/18/2024 - 5 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 2/1/2024 - 5 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/19/2024 - 4 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 6/13/2024 - 23 days ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/13/2024 - 23 days ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/13/2024 - 23 days ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/14/2024 - 22 days ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/14/2024 - 22 days ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/14/2024 - 22 days ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/14/2024 - 22 days ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/14/2024 - 22 days ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/3/2024 - 3 days ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/1/2024 - 5 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR